Covered recipient · General Payments record
RACHEL ANN ROSENBAUM
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$4,179.37
- Reported across 141 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $639.84 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $272.99 | 19 |
| BOSTON SCIENTIFIC CORPORATION | $96.72 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $92.30 | 3 |
| Medtronic, Inc. | $51.93 | 2 |
| PFIZER INC. | $27.53 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $19.02 | 1 |
| Sumitomo Pharma America, Inc. | $18.24 | 1 |
| Averitas Pharma Inc. | $15.98 | 1 |
| Collegium Pharmaceutical, Inc. | $15.64 | 1 |
| UCB, Inc. | $15.57 | 1 |
| Neurelis, Inc. | $13.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.34 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974560 | CMS |
| ABBVIE INC. | $8.38 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974562 | CMS |
| ABBVIE INC. | $31.10 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974564 | CMS |
| ABBVIE INC. | $20.48 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974566 | CMS |
| ABBVIE INC. | $7.95 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974568 | CMS |
| ABBVIE INC. | $5.57 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974570 | CMS |
| ABBVIE INC. | $18.33 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974572 | CMS |
| ABBVIE INC. | $4.00 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974574 | CMS |
| ABBVIE INC. | $28.18 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974576 | CMS |
| ABBVIE INC. | $13.70 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974578 | CMS |
| ABBVIE INC. | $7.10 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974580 | CMS |
| ABBVIE INC. | $5.70 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974582 | CMS |
| ABBVIE INC. | $26.00 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974584 | CMS |
| ABBVIE INC. | $11.39 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974586 | CMS |
| ABBVIE INC. | $16.58 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974588 | CMS |
| ABBVIE INC. | $18.75 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974590 | CMS |
| ABBVIE INC. | $3.04 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974592 | CMS |
| ABBVIE INC. | $13.68 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974594 | CMS |
| ABBVIE INC. | $7.72 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105974596 | CMS |
| Averitas Pharma Inc. | $15.98 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133443907 | CMS |
| Boston Scientific Corporation | $96.72 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092528865 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $19.02 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144455037 | CMS |
| Collegium Pharmaceutical, Inc. | $15.64 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135240451 | CMS |
| Medtronic, Inc. | $24.80 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119559772 | CMS |
| Medtronic, Inc. | $27.13 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119559774 | CMS |
| Neurelis, Inc. | $13.92 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145652504 | CMS |
| Novartis Pharmaceuticals Corporation | $30.14 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087305881 | CMS |
| Novartis Pharmaceuticals Corporation | $30.71 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087305893 | CMS |
| Novartis Pharmaceuticals Corporation | $31.45 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087305901 | CMS |
| PFIZER INC. | $27.53 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131725726 | CMS |
| Sumitomo Pharma America, Inc. | $18.24 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148911624 | CMS |
| UCB, Inc. | $15.57 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143342553 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.